Zaleplon.
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*
D000081:Acetamides; D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D011743:Pyrimidines; C085665:zaleplon